Koers Regnum Corp. Other OTC
Aandelen
RGMP
US75915R1068
Biotechnologie & Medisch Onderzoek
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 3,1 mln. 2,85 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | - 0 | Nettowinst (verlies) 2022 | - 0 | EV/omzet 2021 | - |
Nettoschuld 2021 | 22,06K 20,31K | Nettoschuld 2022 | 773K 711K | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-13
x | K/w-verhouding 2022 |
-3,97
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 1,18% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,63% | 50,93 mld. | |
-0,09% | 42,12 mld. | |
+49,62% | 42,05 mld. | |
-4,96% | 29,18 mld. | |
+11,18% | 26,02 mld. | |
-21,95% | 18,9 mld. | |
+8,61% | 13,21 mld. | |
+24,73% | 12,17 mld. | |
+28,31% | 12,16 mld. |